TCM
Tang Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-266,500
| Closed | -$9.07M | – | 207 |
|
|
2025
Q1 | $9.07M | Hold |
266,500
| – | – | 0.5% | 50 |
|
|
2024
Q4 | $10.5M | Hold |
266,500
| – | – | 0.69% | 39 |
|
|
2024
Q3 | $12.5M | Sell |
266,500
-50,000
| -16% | -$2.35M | 0.89% | 38 |
|
|
2024
Q2 | $17.1M | Buy |
316,500
+200,000
| +172% | +$10.8M | 1.74% | 16 |
|
|
2024
Q1 | $7.94M | Sell |
116,500
-98,500
| -46% | -$6.71M | 0.83% | 43 |
|
|
2023
Q4 | $13.5M | Buy |
+215,000
| New | +$13.5M | 1.24% | 22 |
|
|
2023
Q3 | – | Sell |
-20,000
| Closed | -$1.12M | – | 111 |
|
|
2023
Q2 | $1.12M | Buy |
+20,000
| New | +$1.12M | 0.17% | 80 |
|
|
2023
Q1 | – | Sell |
-10,000
| Closed | -$407K | – | 112 |
|
|
2022
Q4 | $407K | Sell |
10,000
-40,000
| -80% | -$1.63M | 0.06% | 78 |
|
|
2022
Q3 | $3.27M | Buy |
+50,000
| New | +$3.27M | 0.4% | 56 |
|